Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Biochemical and Biophysical Research Communications|November 4, 2006
Small heat shock proteins protect against alpha-synuclein-induced toxicity and aggregationTiago Fleming Outeiro, Jochen Klucken, Katherine E Strathearn, et al.
Human Molecular Genetics|January 25, 2011
Cyclin-G-associated kinase modifies α-synuclein expression levels and toxicity in Parkinson's disease: results from the GenePD StudyAlexandra Dumitriu, Chris D Pacheco, Jemma B Wilk, et al.
Brain Research|February 8, 2014
Neuroprotective effects of anthocyanin- and proanthocyanidin-rich extracts in cellular models of Parkinson׳s diseaseKatherine E Strathearn, Gad G Yousef, Mary H Grace, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
Protective effects of polyphenol-rich extracts against neurotoxicity elicited by paraquat or rotenone in cellular models of Parkinson's diseaseMitali A Tambe, Aurelie de Rus Jacquet, Katherine E Strathearn, et al.
Nature Genetics|February 3, 2009
Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicityAaron D Gitler, Alessandra Chesi, Melissa L Geddie, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2007
The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasisAaron D Gitler, Brooke J Bevis, James Shorter, et al.
Molecular and Cellular Neurosciences|February 8, 2018
Acrolein-mediated neuronal cell death and alpha-synuclein aggregation: Implications for Parkinson's diseaseAbeje Ambaw, Lingxing Zheng, Mitali A Tambe, et al.
Molecular Neurodegeneration|September 9, 2020
Two C-terminal sequence variations determine differential neurotoxicity between human and mouse α-synucleinNatalie Landeck, Katherine E Strathearn, Daniel Ysselstein, et al.
Antioxidants (Basel, Switzerland)|July 29, 2023
Protective Effects of Polyphenol-Rich Extracts against Neurotoxicity Elicited by Paraquat or Rotenone in Cellular Models of Parkinson's DiseaseMitali A Tambe, Aurélie de Rus Jacquet, Katherine E Strathearn, et al.
Science (New York, N.Y.)|June 26, 2007
Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's diseaseTiago Fleming Outeiro, Eirene Kontopoulos, Stephen M Altmann, et al.
Pageof 2